Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales

Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study

(2023) Alexis Maillard et al.   International Journal of Antimicrobial Agents

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

(2021) Pranita D Tamma et al.   CLINICAL INFECTIOUS DISEASES

A Primer on AmpC Beta-Lactamases: Necessary Knowledge for an Increasingly Multidrug-Resistant World

(2019) Pranita D Tamma et al.   CLINICAL INFECTIOUS DISEASES

Nudging In MicroBiology Laboratory Evaluation (NIMBLE): A scoping review

(2019) Bradley J. Langford et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Infections caused by naturally AmpC-producing Enterobacteriaceae: can we use third generation cephalosporins? A narrative review

(2019) A. Mizrahi et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase

(2018) Rebekka Kohlmann et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Microbiology Comment Nudge Improves Pneumonia Prescribing

(2018) Mary A Musgrove et al.   Open Forum Infectious Diseases

Diagnosis and Treatment ofClostridium difficilein Adults

(2015) Natasha Bagdasarian et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae

(2013) Pranita D. Tamma et al.   CLINICAL INFECTIOUS DISEASES

Acute bacterial skin and skin structure infections: current perspective

(2011) Megha Shah et al.   INDIAN JOURNAL OF DERMATOLOGY